5th Dermatology Drug Development Summit Europe

Kongressthemen
Going Beyond Symptomatic Treatment: Uncovering Targetable Pathways, Translational Techniques and Navigating European Healthcare Infrastructure to Advance Novel R and D for Small Molecules, Biologics, mAb's and beyond!

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2124113-3?pid=4832

Speakers: Anna-Lena Spetz, CSO, TIRmed, Betsy Hughes- Formella, Co-Founder & Chief Scientific Officer, Dermaliq Therapeutics, David Cook, Chief Scientific Officer, Blueberry Therapeutics Ltd, & more

https://go.evvnt.com/2124113-2?pid=4832

Frau Clarice Handley